The Gut Bacteria Metabolite IPA Enhances Immune Checkpoint Blockade Efficacy

Skip Nav Destination

March 26, 2024

Major Finding: Gut bacteria collaborate to produce the metabolite IPA, which modulates the T-cell stemness program.

Concept: IPA enhances H3K27 acetylation at the TCF7 super enhancer to facilitate progenitor exhausted CD8⁺ T-cell generation.

Impact: Therapeutically enhancing IPA production could improve immunotherapy response in multiple cancers.

DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-047

Article Type: Research Watch

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

The Gut Bacteria Metabolite IPA Enhances Immune Checkpoint Blockade Efficacy Available to Purchase